Vivendy Therapeutics
-
2006
Company Description
Vivendy Therapeutics is engaged in the development of enzyme replacement therapy.
Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Company Website:
-
Company E-mail:
-
Company Address:
Peter Merian-Str. 45BaselSwitzerland -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits